Company Filing History:
Years Active: 2025
Title: Jillian Thompson: Innovator in Ribonucleic Acid Research
Introduction
Jillian Thompson is a prominent inventor based in Calgary, Canada. She has made significant contributions to the field of molecular biology, particularly in the area of ribonucleic acid (RNA) research. With a total of 2 patents, her work focuses on innovative compositions that regulate the production of interfering ribonucleic acids.
Latest Patents
Thompson's latest patents include a composition for regulating the production of interfering ribonucleic acid. This composition comprises a recombinant plasmid (RP) with a sequence of nucleic acids. The sequence includes a start region, an end region, and an insert positioned between these regions. The insert encodes for a sequence of micro interfering ribonucleic acid (miRNA) that may be complementary to a sequence of target messenger RNA (mRNA). This mRNA encodes for the translation of a target biomolecule. The miRNA can cause the target mRNA to be degraded or inactivated, leading to a decrease in the bioavailability of the target biomolecule. In some embodiments, the target biomolecule is an immune checkpoint protein.
Career Highlights
Jillian Thompson is currently employed at Wyvern Pharmaceuticals Inc., where she continues to advance her research in RNA technology. Her innovative work has positioned her as a key figure in the development of therapeutic strategies targeting immune checkpoint proteins.
Collaborations
Thompson collaborates with various professionals in her field, including her coworker, Bradley G Thompson. Their combined expertise contributes to the advancement of research and development in the pharmaceutical industry.
Conclusion
Jillian Thompson's contributions to RNA research and her innovative patents highlight her role as a leading inventor in the field. Her work at Wyvern Pharmaceuticals Inc. continues to pave the way for advancements in therapeutic applications.